{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:06:28Z","timestamp":1790197588333,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":41,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011684","name":"Crohn's & Colitis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011684","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007028","name":"Leona M and Harry B Helmsley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cgh.2026.08.019","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:24:44Z","timestamp":1787930684000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serious Infections in Patients With Inflammatory Bowel Disease and Corticosteroids: A Propensity Score\u2013Matched Study"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1906-4982","authenticated-orcid":false,"given":"Anders","family":"Forss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Axelrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"S\u00f6derling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"M\u00e5rild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Strid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Halfvarson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Nordenvall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Hedin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Rejler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Grip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika L.","family":"Fagerberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"M\u00e5rild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Hreinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Ol\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Grip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann P.","family":"Hreinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Halfvarson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pontus","family":"Naucler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas F.","family":"Ludvigsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Ol\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2026.08.019_bib1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.cgh.2018.07.013","article-title":"Balancing benefit vs risk of immunosuppressive therapy for individual patients with inflammatory bowel diseases","volume":"17","author":"Beaugerie","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.08.019_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jpeds.2021.06.076","article-title":"Serious infections in pediatric inflammatory bowel disease 2002-2017-A nationwide cohort study","volume":"238","author":"Ludvigsson","year":"2021","journal-title":"J Pediatr"},{"key":"10.1016\/j.cgh.2026.08.019_bib3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/ibd\/izac097","article-title":"The risk of serious infections before and after anti-TNF therapy in inflammatory bowel disease: a retrospective cohort study","volume":"29","author":"Holmgren","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2026.08.019_bib4","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1080\/00365521.2021.1924259","article-title":"Adult-onset inflammatory bowel disease and rate of serious infections compared to the general population: a nationwide register-based cohort study 2002-2017","volume":"56","author":"Ludvigsson","year":"2021","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.08.019_bib5","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.cgh.2022.07.032","article-title":"Comparative risk of serious infections with biologic agents and oral small molecules in inflammatory bowel diseases: a systematic review and meta-analysis","volume":"21","author":"Solitano","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.08.019_bib6","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.14309\/ajg.0000000000002961","article-title":"Comparative risk of serious infection with vedolizumab vs anti-tumor necrosis factor in inflammatory bowel disease: results from nationwide Swedish registers","volume":"119","author":"Karlqvist","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.08.019_bib7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/j.gastro.2018.04.012","article-title":"Risk of serious and opportunistic infections associated with treatment of inflammatory bowel diseases","volume":"155","author":"Kirchgesner","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.08.019_bib8","article-title":"Risk of serious infections in patients with inflammatory bowel disease treated with biologic and small molecule therapies: a nationwide cohort study","volume":"20","author":"Axelrad","year":"2025","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2026.08.019_bib9","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.cgh.2023.10.013","article-title":"Histologic activity in inflammatory bowel disease and risk of serious infections: a nationwide study","volume":"22","author":"Marild","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.08.019_bib10","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/ecco-jcc\/jjae091","article-title":"ECCO Guidelines on therapeutics in Crohn's disease: medical treatment","volume":"18","author":"Gordon","year":"2024","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2026.08.019_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO Guidelines on therapeutics in ulcerative colitis: medical treatment","volume":"16","author":"Raine","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2026.08.019_bib12","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/cid\/ciae129","article-title":"Executive summary: state-of-the-art review: unintended consequences: risk of opportunistic infections associated with long-term glucocorticoid therapies in adults","volume":"78","author":"Chastain","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2026.08.019_bib13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1053\/j.gastro.2008.01.012","article-title":"Risk factors for opportunistic infections in patients with inflammatory bowel disease","volume":"134","author":"Toruner","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.08.019_bib14","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.3748\/wjg.v25.i18.2240","article-title":"Nested case-control study on risk factors for opportunistic infections in patients with inflammatory bowel disease","volume":"25","author":"Gong","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.08.019_bib15","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/ajg.2014.313","article-title":"Oral corticosteroids and the risk of serious infections in patients with elderly-onset inflammatory bowel diseases","volume":"109","author":"Brassard","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.08.019_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158017","article-title":"Corticosteroid use and complications in a US inflammatory bowel disease cohort","volume":"11","author":"Waljee","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2026.08.019_bib17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00535-012-0686-9","article-title":"A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease","volume":"48","author":"Naganuma","year":"2013","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.08.019_bib18","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/ajg.2012.218","article-title":"Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT registry","volume":"107","author":"Lichtenstein","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.08.019_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12876-017-0602-0","article-title":"Inflammatory Bowel Disease (IBD) pharmacotherapy and the risk of serious infection: a systematic review and network meta-analysis","volume":"17","author":"Wheat","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.cgh.2026.08.019_bib20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10654-025-01226-9","article-title":"The healthcare system in Sweden","volume":"40","author":"Ludvigsson","year":"2025","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.cgh.2026.08.019_bib21","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10654-009-9350-y","article-title":"The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research","volume":"24","author":"Ludvigsson","year":"2009","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.cgh.2026.08.019_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10654-025-01221-0","article-title":"Diagnostic accuracy in the Swedish national patient register: a review including diagnoses in the outpatient register","volume":"40","author":"Everhov","year":"2025","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.cgh.2026.08.019_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","article-title":"Registers of the Swedish total population and their use in medical research","volume":"31","author":"Ludvigsson","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.cgh.2026.08.019_bib24","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/00365521.2021.1884894","article-title":"Capturing biologic treatment for IBD in the Swedish Prescribed Drug Register and the Swedish National Patient Register - a validation study","volume":"56","author":"Br\u00f6ms","year":"2021","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.08.019_bib25","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.cgh.2026.08.019_bib26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10654-019-00511-8","article-title":"The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research","volume":"34","author":"Ludvigsson","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.cgh.2026.08.019_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/02841860802247664","article-title":"The completeness of the Swedish Cancer Register: a sample survey for year 1998","volume":"48","author":"Barlow","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1016\/j.cgh.2026.08.019_bib28","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10654-017-0316-1","article-title":"The Swedish cause of death register","volume":"32","author":"Brooke","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.cgh.2026.08.019_bib29","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1080\/00365521.2019.1660799","article-title":"Swedish Inflammatory Bowel Disease Register (SWIBREG) - a nationwide quality register","volume":"54","author":"Ludvigsson","year":"2019","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.08.019_bib30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/CLEP.S191914","article-title":"Cohort profile: ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden)","volume":"11","author":"Ludvigsson","year":"2019","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.cgh.2026.08.019_bib31","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1080\/00365521.2020.1740778","article-title":"The use of ICD codes to identify IBD subtypes and phenotypes of the Montreal classification in the Swedish National Patient Register","volume":"55","author":"Shrestha","year":"2020","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.08.019_bib32","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/00365521.2016.1246605","article-title":"Validating inflammatory bowel disease (IBD) in the Swedish national patient register and the Swedish Quality Register for IBD (SWIBREG)","volume":"52","author":"Jakobsson","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.08.019_bib33","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2147\/CLEP.S358031","article-title":"Identification of childhood-onset inflammatory bowel disease in Swedish healthcare registers: a validation study","volume":"14","author":"Mouratidou","year":"2022","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.cgh.2026.08.019_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjaf145","article-title":"Impact of concomitant corticosteroid use on adverse events in ulcerative colitis clinical trials","volume":"19","author":"Hamam","year":"2025","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2026.08.019_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cgh.2019.02.044","article-title":"Comparative risk of serious infections with biologic and\/or immunosuppressive therapy in patients with inflammatory bowel diseases: a systematic review and meta-analysis","volume":"18","author":"Singh","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.08.019_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2026.04.015","article-title":"Serious infection in inflammatory bowel diseases patients treated with Vedolizumab, Ustekinumab, Janus kinase inhibitors, anti-tumor necrosis factor or aminosalicylates","author":"Bertrand","year":"2026","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.08.019_bib37","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/ecco-jcc\/jjad190","article-title":"Impact of baseline corticosteroid use on the efficacy and safety of upadacitinib in patients with ulcerative colitis: a post hoc analysis of the phase 3 clinical trial Programme","volume":"18","author":"Raine","year":"2024","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2026.08.019_bib38","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/ecco-jcc\/jjab052","article-title":"ECCO Guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease","volume":"15","author":"Kucharzik","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2026.08.019_bib39","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1007\/s10620-015-3796-4","article-title":"Cost-effectiveness of prophylaxis against Pneumocystis jiroveci pneumonia in patients with Crohn's disease","volume":"60","author":"Okafor","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2026.08.019_bib40","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/ajg.2016.433","article-title":"Crohn's disease activity and concomitant immunosuppressants affect the risk of serious and opportunistic infections in patients treated with adalimumab","volume":"111","author":"Osterman","year":"2016","journal-title":"Am J Gastroenterol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526006427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526006427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:41:51Z","timestamp":1790196111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356526006427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":40,"alternative-id":["S1542356526006427"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2026.08.019","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serious Infections in Patients With Inflammatory Bowel Disease and Corticosteroids: A Propensity Score\u2013Matched Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2026.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}]}}